✦ LIBER ✦

Stromal factors involved in prostate carcinoma metastasis to bone

✍ Scribed by Carlton R. Cooper; Christopher H. Chay; James D. Gendernalik; Hyung-Lae Lee; Jasmine Bhatia; Russell S. Taichman; Laurie K. McCauley; Evan T. Keller; Kenneth J. Pienta

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 289 KB
Volume: 97
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.11181

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

Prostate carcinoma (pc) frequently metastasizes to bone, where it causes significant morbidity and mortality. stromal elements in the primary and metastatic target organs are important mediators of tumor cell intravasation, chemoattraction, adhesion to target organ microvascular endothelium, extravasation, and growth at the metastatic site.

Methods:

The role of stromal factors in bone metastasis was determined with a cyclic dna microarray comparison of a bone-derived cell pc cell line with a soft tissue-derived cell pc cell line and by evaluating the effects of selected stromal components on pc cell chemotaxis, cell adhesion to human bone marrow endothelium (hbme), and pc cell growth.

Results:

The authors demonstrate that pc cells express protease-activated receptor 1 (par1; thrombin receptor), and its expression is up-regulated in pc compared with normal prostate tissue. in addition, this overexpression was very pronounced in bone-derived pc cell lines (vcap and pc-3) compared with soft tissue pc cell lines (ducap, du145, and lncap). the authors report that bone stromal factors, including stromal cell-derived factor 1 (sdf-1) and collagen type i peptides, are chemoattractants for pc cells, and they demonstrate that some of these factors (e.g., extracellular matrix components, transforming growth factor beta, bone morphogenic proteins [bmps], and sdf-1) significantly alter pc-hbme interaction in vitro. finally, stromal factors, such as bmps, can regulate the proliferation of pc cells in vitro.

Conclusions:

Soluble and insoluble elements of the stroma are involved in multiple steps of pc metastasis to bone. the authors hypothesize that par1 may play a central role in prostate tumorigenesis.

📜 SIMILAR VOLUMES

Role of stromal-derived cytokines and gr

Role of stromal-derived cytokines and growth factors in bone metastasis

✍ G. David Roodman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

## Background: Interactions between bone marrow-derived cytokines, growth factors, and tumors play a critical role in both the homing of tumors to the bone and the development of bone metastasis. bone is a storehouse of latent growth factors produced by stromal cells and osteoblasts that, when acti

Steps in prostate cancer progression tha

Steps in prostate cancer progression that lead to bone metastasis

✍ Jung-Kang Jin; Farshid Dayyani; Gary E. Gallick 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 385 KB

## Abstract Prostate cancer is a complex disease in which metastasis to the bone is the main cause of death. Initial stages of metastasis are generally similar to those for most solid tumors; however, the mechanisms that underlie the homing of prostate tumor cells to the bone are not completely und

Plasma osteopontin : Associations with s

Plasma osteopontin : Associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma

✍ Sebastien J. Hotte; Eric W. Winquist; Larry Stitt; Sylvia M. Wilson; Ann F. Cham 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

## Background: Osteopontin (opn) is a secreted glycoprotein that is detectable in human body fluids. its increased expression has been found in many malignancies, and a stimulatory effect on human prostate carcinoma cells in vitro has been demonstrated. plasma opn levels have been associated with t

Factors affecting bone mineral density i

Factors affecting bone mineral density in patients with prostate carcinoma before and after orchidectomy

✍ Mayank M. Agarwal; Niranjan Khandelwal; Arup K. Mandal; Satyawati V. Rana; Vivek 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

## Abstract ## BACKGROUND Orchidectomy is an accepted form of androgen‐deprivation therapy (ADT) for prostate carcinoma. Osteoporosis is common in elderly individuals and is accelerated by ADT. The authors studied changes in bone mineral density (BMD) after ADT and factors that affected those chan

Prostate carcinoma staging: Clinical uti

Prostate carcinoma staging: Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen

✍ Juan Morote; José Antonio Lorente; Gloria Encabo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 2 views

BACKGROUND. Biochemical markers of bone disease have been of interest as part of the investigation of prostate carcinoma and the monitoring of skeletal involvement. Bone isoenzyme of the alkaline phosphatase (BAP) is an indicator of the metabolism of the osteoblasts. An immunoradioanalyses with two

Prostatic carcinoma metastatic to bone:

Prostatic carcinoma metastatic to bone: Sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material

✍ Niranjan T. Shah; Steven E. Tuttle; Stephan L. Storbel; Leena Gandhi 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

Decalcified bone marrow biopsies containing metastatic tumor from 36 patients were stained for prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) using the avidin biotin compIex (ABC) immunoperoxidase technique. Of these patients, 22 had known prostate primaries, ten had known nonp